RxDoctor Payments Data

Richard Ogbuji, MD

Neurological Surgery · Springfield, MANPI 1295097533

Payments from drug & device makers

What this record shows

This record is dominated by grants: $21,250 of the $21,514 with a category attached, or 98.8%. 5 manufacturers reported payments, led by Medtronic at 52.5% of the total. Reporting peaked in 2019 at $21,436 and has fallen 99.9% since, to $20 in 2024.

$21,514in general payments, 2019–2025

Across 7 payments — averaging $3073.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • Boston Scientific$10K
  • Abbott$186
  • Globus Medical$22
  • CSL Behring$20

What the payments were for

  • Grants$21,25099%
  • Food & beverage$2441%
  • Education$200%

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)2$11,286
Boston Scientific1$10,000
Abbott2$186
Globus Medical1$22
CSL Behring1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,514 in reported general payments places this provider in the 80th percentile of 183 neurological surgery providers in Massachusetts.

See all neurological surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$166,274
Medicare patients
170
Services billed
354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone11$39

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →